Name: MASIMO CORP (MASI) Stock
Brand: MASIMO CORP
Rating: 4.5 (3 reviews)

MASI Latest News, Press Relases and Analysis

All

Press Releases

5 days ago - By: Zacks Investment Research - Mentions: FMS MMSI WST

Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now

6 days ago - By: Benzinga

$1000 Invested In Masimo 10 Years Ago Would Be Worth This Much Today

6 days ago - By: Zacks Investment Research - Mentions: MMSI WST OPK

Here's Why You Should Add OPKO Health Stock to Your Portfolio

7 days ago - By: Halper Sadeh LLC

Halper Sadeh LLC Encourages Masimo Corporation Shareholders to Contact the Firm to Discuss Their Rights

7 days ago - By: Zacks Investment Research - Mentions: BSX MMSI WST

WST Stock Up on Q3 Earnings Beat, EPS View Raised on Demand & FX Benefit

9 days ago - By: Masimo

Masimo to Report Third Quarter 2025 Financial Results after Market Close on Tuesday, November 4

10 days ago - By: Zacks Investment Research

Here's Why Masimo (MASI) is a Strong Growth Stock

a month ago - By: Zacks Investment Research

Here's Why Masimo (MASI) is a Strong Growth Stock

13 days ago - By: Zacks Investment Research - Mentions: MMSI WST AVTR

Avantor Partners With BlueWhale Bio to Advance CAR-T Manufacturing

13 days ago - By: Benzinga - Mentions: ACN HD

Recent Report Shows That Rep. Kevin Hern Sold Up to $200K Worth of Accenture Stock

17 days ago - By: Zacks Investment Research - Mentions: BDX RMD SOLV

BD Stock Down Despite Making Progress in the Treatment of PAD Lesions

17 days ago - By: Zacks Investment Research - Mentions: MMSI WST INSP

INSP Shares Down Despite Strong Clinical Data From Inspire V Trials

17 days ago - By: Zacks Investment Research - Mentions: EW PLSE NDRA

Pulse Biosciences Unveils Promising First-in-Human Data for nPulse

2 months ago - By: Zacks Investment Research - Mentions: RL ATRO BYD LRN

New Strong Buy Stocks for September 4th

20 days ago - By: Zacks Investment Research - Mentions: BDX RMD SOLV

BD Stock Down Despite Tie-Up to Boost Single-Cell Sequencing Workflow

21 days ago - By: Masimo

Masimo to Host Investor Day on December 3, 2025

23 days ago - By: Masimo

In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones

a month ago - By: Masimo

Masimo Completes Sale of Consumer Audio Business to HARMAN International

a month ago - By: Kahn Swick & Foti, LLC

MASIMO INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Masimo Corporation - MASI

a month ago - By: Masimo

New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs

2 months ago - By: Masimo

Masimo Announces Expansion of Strategic Partnership with Philips

2 months ago - By: Zacks Investment Research - Mentions: PAHC EXAS NVST

Should You Continue to Hold EXAS Stock in Your Portfolio?

2 months ago - By: Zacks Investment Research - Mentions: PAHC NVST GEHC

Here's Why You Should Add PAHC Stock to Your Portfolio Right Now

2 months ago - By: Zacks Investment Research - Mentions: GMED PAHC NVST

Should You Hold Onto Globus Medical Stock in Your Portfolio for Now?

2 months ago - By: Zacks Investment Research - Mentions: CRL PAHC NVST

Is it the Right Time to Add CRL Stock to Your Portfolio Now?

2 months ago - By: Zacks Investment Research - Mentions: QGEN PAHC NVST

QIAGEN Stock May Benefit From the US Clearance of QIAstat-Dx Rise

2 months ago - By: Zacks Investment Research - Mentions: RMD PAHC NVST

Is it Worth Retaining ResMed Stock in Your Portfolio Now?

2 months ago - By: Zacks Investment Research - Mentions: CRL PAHC NVST

Charles River Stock May Benefit From Joining EASYGEN Consortium

2 months ago - By: Zacks Investment Research - Mentions: BIO PAHC NVST

Is it Apt to Hold Bio-Rad Stock in Your Portfolio Now?

2 months ago - By: Masimo

Masimo to Present in the Wells Fargo Healthcare Conference

2 months ago - By: Zacks Investment Research - Mentions: TAL SCI POST OKTA

MASIMO CORP (MASI) Stock News

MASI Latest News, Press Relases and Analysis

Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now

$1000 Invested In Masimo 10 Years Ago Would Be Worth This Much Today

Here's Why You Should Add OPKO Health Stock to Your Portfolio

Halper Sadeh LLC Encourages Masimo Corporation Shareholders to Contact the Firm to Discuss Their Rights

WST Stock Up on Q3 Earnings Beat, EPS View Raised on Demand & FX Benefit

Masimo to Report Third Quarter 2025 Financial Results after Market Close on Tuesday, November 4

Here's Why Masimo (MASI) is a Strong Growth Stock

Here's Why Masimo (MASI) is a Strong Growth Stock

Avantor Partners With BlueWhale Bio to Advance CAR-T Manufacturing

Recent Report Shows That Rep. Kevin Hern Sold Up to $200K Worth of Accenture Stock

BD Stock Down Despite Making Progress in the Treatment of PAD Lesions

INSP Shares Down Despite Strong Clinical Data From Inspire V Trials

Pulse Biosciences Unveils Promising First-in-Human Data for nPulse

New Strong Buy Stocks for September 4th

BD Stock Down Despite Tie-Up to Boost Single-Cell Sequencing Workflow

Masimo to Host Investor Day on December 3, 2025

In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones

Masimo Completes Sale of Consumer Audio Business to HARMAN International

MASIMO INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Masimo Corporation - MASI

New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs

Masimo Announces Expansion of Strategic Partnership with Philips

Should You Continue to Hold EXAS Stock in Your Portfolio?

Here's Why You Should Add PAHC Stock to Your Portfolio Right Now

Should You Hold Onto Globus Medical Stock in Your Portfolio for Now?

Is it the Right Time to Add CRL Stock to Your Portfolio Now?

QIAGEN Stock May Benefit From the US Clearance of QIAstat-Dx Rise

Is it Worth Retaining ResMed Stock in Your Portfolio Now?

Charles River Stock May Benefit From Joining EASYGEN Consortium

Is it Apt to Hold Bio-Rad Stock in Your Portfolio Now?

Masimo to Present in the Wells Fargo Healthcare Conference

Bet on 5 Top-Ranked Stocks With Rising P/E